Hepatitis Diagnostic Tests Market 2030: Trends Shaping the Future of Healthcare
The global hepatitis diagnostic tests market was valued at USD 3.82 billion in 2023 and is projected to reach USD 5.90 billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030. Hepatitis is a medical condition characterized by pain and inflammation of the liver, and it can manifest as either an acute or chronic condition, depending on the patient's health profile. Clinical data highlights a significant mortality rate associated with hepatitis. Globally, approximately 300 to 350 million individuals are carriers of Hepatitis B and C viruses, many of whom remain asymptomatic for decades. This underlines the importance of diagnostic testing to identify, monitor, and manage these infections effectively. The increasing introduction of molecular diagnostics and growing awareness about hepatitis are key factors boosting the demand for diagnostic tests during the forecast period. Rising incidence rates of Hepatitis B and C—particularly in both adult and pediatric populations—h...